TY - JOUR
T1 - Venous Thromboembolism in COVID-19
T2 - Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment
AU - Aryal, Madan Raj
AU - Gosain, Rohit
AU - Donato, Anthony
AU - Pathak, Ranjan
AU - Bhatt, Vijaya Raj
AU - Katel, Anjan
AU - Kouides, Peter
N1 - Funding Information:
MRA, RG, and AK were involved in initial literature search, data collection, and manuscript writing. RP, VRB, and AD drafted the subsequent manuscript. PK is the senior author and subsequently finalized the manuscript for submission. MRA is the primary author.
Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Purpose of Review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. Recent Findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Summary: Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.
AB - Purpose of Review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. Recent Findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Summary: Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.
KW - COVID-19
KW - Deep vein thrombosis
KW - Extended prophylaxis
KW - Pulmonary embolism
KW - Thromboprophylaxis
KW - Venous thromboembolism
UR - http://www.scopus.com/inward/record.url?scp=85086321887&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086321887&partnerID=8YFLogxK
U2 - 10.1007/s11886-020-01327-9
DO - 10.1007/s11886-020-01327-9
M3 - Review article
C2 - 32529517
AN - SCOPUS:85086321887
VL - 22
JO - Current Cardiology Reports
JF - Current Cardiology Reports
SN - 1523-3782
IS - 7
M1 - 52
ER -